NewGenIvf Group Ltd. has strategically positioned itself to expand its fertility services by appointing Thorain Ko as business development director, focusing on developing its lifetime egg freezing initiative across Asia.
Ko, with over thirty years of experience in healthcare business development, will lead the company's efforts to grow its recently launched egg freezing service. The service offers a unique 'one charge, no worries' model that allows women to freeze eggs indefinitely, addressing complex reproductive limitations in markets like China, Hong Kong, and Singapore.
The fertility provider aims to overcome regional restrictions that currently limit egg storage to ten years and prohibit single women from freezing eggs. By targeting affluent women who want reproductive flexibility, NewGenIvf projects significant financial potential, anticipating between $4.95 million and $24.8 million in net profit during its first year of operations.
This strategic move comes as NewGenIvf recently regained compliance with Nasdaq listing requirements and transferred to the Nasdaq Capital Market. The company's bold approach to egg freezing reflects a growing demand for reproductive autonomy among professional women in Asia who are delaying childbirth.
NewGenIvf expects to grow its customer base by 10% over five years, with projected revenues reaching $12 million in the first year. Ko's extensive background in healthcare and direct selling positions the company to effectively navigate and expand this emerging market segment.
